Salvage radiotherapy: A plea for dose-escalation with intensity-modulated radiotherapy

European Journal of Cancer

Volumn 48, Issue 9, 2012, Pages 1415-1416

  Ost, Piet ^a   Cozzarini, Cesare ^b   Bossi, Alberto ^c   Meerleer, Gert De ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANDROGEN DEPRIVATION THERAPY; CANCER PATIENT; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; LETTER; MORBIDITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SALVAGE THERAPY; UNITED STATES; UROGENITAL TRACT DISEASE;

HUMANS; MALE; MODELS, BIOLOGICAL; PROSTATIC NEOPLASMS; SALVAGE THERAPY;

EID: 84861335288     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.01.024     Document Type: Letter

References (13)

1. N. Ohri, A.P. Dicker, E.J. Trabulsi, and T.N. Showalter Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling Eur J Cancer 2011
2. C.R. King, and D.S. Kapp Radiotherapy after prostatectomy: is the evidence for dose escalation out there? Int J Radiat Oncol Biol Phys 71 2 2008 346 350
3. A. Goenka, J.M. Magsanoc, and X. Pei Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy Eur Urol 2011
4. P. Ost, N. Lumen, and A.S. Goessaert High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results Eur Urol 60 2011 842 849
5. B.F. Koontz, S. Das, and K. Temple Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy Med Dosim 34 3 2009 256 260
6. P. Ost, W. De Gersem, and B. De Potter A comparison of the acute toxicity profile between two-dimensional and three-dimensional image-guided radiotherapy for postoperative prostate cancer Clin Oncol (R Coll Radiol) 23 5 2011 344 349
7. P. Ost, G. De Meerleer, W. De Gersem, A. Impens, and W. De Neve Analysis of prostate bed motion using daily cone-beam computed tomography during postprostatectomy radiotherapy Int J Radiat Oncol Biol Phys 79 1 2011 188 194
8. T.N. Showalter, N. Ohri, and K.G. Teti Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy Int J Radiat Oncol Biol Phys 2011
9. A.J. Stephenson, P.T. Scardino, and M.W. Kattan Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 15 2007 2035 2041
10. M. Souvatzoglou, B.J. Krause, and A. Purschel Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer Radiother Oncol 99 2 2011 193 200
11. H.J. Meijer, E.N. van Lin, and O.A. Debats High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy Int J Radiat Oncol Biol Phys 2011
12. M.T. Spiotto, S.L. Hancock, and C.R. King Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients Int J Radiat Oncol Biol Phys 69 1 2007 54 61
13. W.U. Shipley, D. Hunt, and H.R. Lukka Initial report of RTOG 9601, a phase III trial in prostate cancer: effect of anti-androgen therapy (AAT) with bicalutamide during and after radiation therapy (RT) on freedom from progression and incidence of metastatic disease in patients following radical prostatectomy (RP) with p T2-3, N0 disease and elevated PSA levels J Clin Oncol 29 Suppl. 7; abstr. 1 2011